HomeCompareCSII vs PLD

CSII vs PLD: Dividend Comparison 2026

CSII yields 10.00% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.47M in total portfolio value· pulled ahead in Year 3
10 years
CSII
CSII
● Live price
10.00%
Share price
$20.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.8K
Annual income
$1,874.61
Full CSII calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CSII vs PLD

📍 PLD pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSIIPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSII + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CSII pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSII
Annual income on $10K today (after 15% tax)
$850.00/yr
After 10yr DRIP, annual income (after tax)
$1,593.42/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,466,377.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSII + PLD for your $10,000?

CSII: 50%PLD: 50%
100% PLD50/50100% CSII
Portfolio after 10yr
$3.27M
Annual income
$2,629,155.39/yr
Blended yield
80.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CSII
Analyst Ratings
1
Hold
Consensus: Hold
Price Target
$17.50
-12.5% upside vs current
Range: $15.00 — $20.00
Altman Z
6.1
Piotroski
5/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSII buys
0
PLD buys
0
No recent congressional trades found for CSII or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSIIPLD
Forward yield10.00%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$38.8K$6.50M
Annual income after 10y$1,874.61$5,256,436.18
Total dividends collected$14.3K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$17.50$136.00

Year-by-year: CSII vs PLD ($10,000, DRIP)

YearCSII PortfolioCSII Income/yrPLD PortfolioPLD Income/yrGap
1$11,700$1,000.00$11,255$555.24+$445.00CSII
2$13,612$1,093.46$13,062$1,018.59+$550.00CSII
3← crossover$15,754$1,188.96$15,903$1,926.67$149.00PLD
4$18,143$1,286.02$20,839$3,823.32$2.7KPLD
5$20,797$1,384.13$30,464$8,166.08$9.7KPLD
6$23,736$1,482.82$52,054$19,457.30$28.3KPLD
7$26,979$1,581.62$109,886$54,188.93$82.9KPLD
8$30,548$1,680.12$304,030$186,451.18$273.5KPLD
9$34,464$1,777.90$1,166,125$840,813.32$1.13MPLD
10$38,751$1,874.61$6,504,190$5,256,436.18$6.47MPLD

CSII vs PLD: Complete Analysis 2026

CSIIStock

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

Full CSII Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CSII vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSII vs SCHDCSII vs JEPICSII vs OCSII vs KOCSII vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.